Analysis of the antibiotic in the patients with community-acquired pneumonia

doi:10.3969/j.issn.1674-490X.2015.01.018

Medical Reserch and Education ›› 2015, Vol. 32 ›› Issue (1): 76-79.DOI: 10.3969/j.issn.1674-490X.2015.01.018

Previous Articles Next Articles

Analysis of the antibiotic in the patients with community-acquired pneumonia

NAN Kai¹, ZHU Taiping², LIU Siwen³, LIU Sumei², LI Xiaowei⁴, HAO Lifeng²

1. Health and Medical Development Research Center of Hebei Province Science and Technology, Shijiazhuang 050051, China; 2. Shijiazhuang Medical College, Shijiazhuang 050051, China; 3. Hebei Institute of Medical Information, Shijiazhuang 050051, China; 4. College of Traditional Chinese Medicine of Hebei Province, Shijiazhuang 050051, China

Online:2015-02-25 Published:2015-02-25

Abstract

CLC Number:

NAN Kai, ZHU Taiping, LIU Siwen, LIU Sumei, LI Xiaowei, HAO Lifeng. Analysis of the antibiotic in the patients with community-acquired pneumonia[J]. Medical Reserch and Education, 2015, 32(1): 76-79.

[1] 魏风芹, 柴文戍. 社区获得性肺炎诊治新进展[J]. 医学综述, 2008, 14(16): 2465-2467.
[2] 余洪亮, 伦志勇, 戴剑红. 社区获得性肺炎诊断及治疗[J]. 当代医学, 2012, 18(18): 79-80.
[3] 徐红冰, 归成, 刘皋林, 等. 社区获得性肺炎病原学分布及药物治疗概况[J]. 抗感染药学, 2009, 6(1): 9-12.
[4] 刘建华, 刘勇. β-内酰胺类和大环内酯类药物联合应用治疗社区获得性肺炎[J]. 中国抗生素杂志, 2007, 32(1): 1-5, 32.
[5] 宋志芳, 窦维嘉. 口服抗感染药物治疗社区获得性肺炎疗效评价[J]. 中华肺部疾病杂志: 电子版, 2011, 24(5): 365-372.
[6] 张运谋, 余宗洋, 孙茂群. 青霉素、阿奇霉素对社区获得性肺炎治疗的临床观察[J]. 中华全科医学, 2011, 9(7): 1106-1107.
[7] 尹文, 王肖. 社区获得性肺炎抗感染药物的应用策略[J]. 临床误诊误治, 2013, 10(5): 6-8.
[8] 唐贞明, 凌宙贵, 刘卫, 等. 医院与社区获得性肺炎的病原菌分布及耐药性[J]. 中华医院感染学杂志, 2014, 24(5): 1092-1094.
[9] 范炤, 王素萍, 赵启玉, 等. 社区获得性肺炎流行特征及病原学分布[J]. 中国公共卫生, 2008, 24(7): 825-827.
[10] 陈光福, 胡元生, 沈继龙, 等. 社区获得性肺炎的病原体调查与药物敏感性分析[J]. 中华疾病控制杂志, 2009, 13(3): 273-276.
[11] 林榜素, 庄剑平, 胡容, 等. 高龄社区获得性肺炎的细菌学及其耐药性研究[J]. 中国全科医学, 2012, 15(13): 1523-1525.
[12] 陈庆青, 宋志芳. 经验性抗感染治疗急诊病房社区获得性肺炎疗效评价[J]. 中华肺部疾病杂志: 电子版, 2012, 5(3): 203-208.
[13] 刘向欣, 尹素凤, 刘运秋. 医院与社区获得性肺炎患者病原菌分布及耐药性分析[J]. 现代预防医学, 2013, 40(23): 4469-4471, 4474.
[14] JOVANOVICH A J, GINDE A A, HOLMEN J, et al. Vitamin D level and risk of community-acquired pneumonia and sepsis[J]. Nutrients, 2014, 6(6): 2196-2205.
[15] SCHULERT G S, HAIN P D, WILLIAMS D J. Utilization of viral molecular diagnostics among children hospitalized with community acquired pneumonia[J]. Hosp Pediatr, 2014, 4(6): 372-376.
[16] 郭森. 我院社区获得性肺炎患者抗菌药物的应用分析[J]. 实用心脑肺血管病杂志, 2011, 15(9): 1497-1498.
[17] 王炜, 李鸿雁, 孙海清, 等. 老年社区获得性肺炎的临床特征分析[J]. 华西医学, 2012, 13(6): 863-865.
[18] 张海英, 叶阮健, 李玉珍. 社区获得性肺炎的抗感染药物治疗[J]. 临床药物治疗杂志, 2010, 8(1): 55-60.
[19] 中华医学会呼吸病学分会感染学组. 成人肺炎支原体肺炎诊治专家共识[J]. 中华结核和呼吸杂志, 2010, 33( 9): 643-645.
[20] WATERER G, RELLO J. Why should we measure bacterial load when treating community-acquired pneumonia?[J]. Curr Opin Infect Dis, 2011, 24(2): 137-141.
[21] PAUL S P, WARREN V. Community acquired pneumonia in a three year old child: dealing with a difficult case[J]. Nurs Times, 2010, 106(49/50): 14.
[22] 徐勇胜, 范永琛. 儿童社区获得性肺炎诊治进展[J]. 中国实用儿科杂志, 2011, 26(8): 637-640.
[23] CHARLES P G, CHENG A C, GRAYSON M L. It's time to move beyond trying to predict mortality using severity assessment tools in community-acquired pneumonia[J]. Intern Med J, 2014, 44(11): 1148.
[24] WUNDERINK R G, LATERRE P F, FRANCOIS B, et al. Recombinant tissue factor pathway inhibitor in severe community-acquired pneumonia: a randomized trial[J]. Am J Respir Crit Care Med, 2011, 183(11): 1561-1568.
[25] 孙志泉. 高龄社区获得性肺炎的细菌学及药敏分析[J]. 临床肺科杂志, 2013, 18(10): 1796-1798.

Analysis of the antibiotic in the patients with community-acquired pneumonia

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 2

Recommended Articles

Metrics

Comments

[1]	. [J]. Medical Reserch and Education, 2019, 36(6): 15-20.
[2]	CAO Lijun,YANG Jing,GENG Fengzhen,LI Huiqing,SHI Zheng,SHI Dongyan. Retrospective report of clinical characterizations of an Enterobacter cloacae carrying NDM-1 associated with urinary tract infection [J]. Medical Reserch and Education, 2014, 31(1): 33-36.